MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceuticals _ Orphan & Rare Diseases
Inozyme Pharma, Inc. (NASDAQ: INZY)*
Organization & Developments: Inozyme Pharma
Parents
Inozyme Pharma, Inc. (NASDAQ: INZY)*
Children
*Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton
2022: Inozyme Pharma (INZY) Investor Presentation - Slideshow_ seekingalpha.com
2023: Inozyme: A Major Catalyst Is Uncomfortably Far Off_ seekingalpha.com
2024: Inozyme: Several Catalysts To Move Rare Disease Pipeline Programs Forward
Jumps
Finance & Acquisitions: Inozyme Pharma
Key People: Inozyme Pharma